Long-Term Management, Pregnancy, and Your Care Team
At a Glance
Generalized pustular psoriasis care requires specialist follow-up, medication-specific lab monitoring, and emotional support. Pregnancy can trigger severe flares, so planning before pregnancy with a dermatologist and high-risk pregnancy specialist is essential when medications require washout.
Managing Generalized Pustular Psoriasis (GPP) over the long term requires more than just skin treatments; it requires a coordinated team and a proactive approach to your physical and emotional well-being. Because GPP is a lifelong condition, your care plan must evolve with your life stages—especially if you are planning a pregnancy.
Pregnancy and GPP
Pregnancy is a recognized trigger for GPP, particularly in the third trimester. This specific form of the disease is sometimes referred to historically as impetigo herpetiformis, an older term that can be confusing as it is absolutely not a herpes infection or an impetigo bacterial infection [1]. It is a high-risk situation that requires urgent, coordinated care between your dermatologist and a Maternal-Fetal Medicine (MFM) specialist—an obstetrician who specializes in high-risk pregnancies [2].
Risks to Mother and Baby
Systemic inflammation from a GPP flare during pregnancy can lead to serious complications for both the mother and the fetus. For the mother, these include low calcium (hypocalcemia), liver abnormalities, and in severe cases, respiratory or heart failure [3][4]. For the baby, severe and uncontrolled inflammation can cause placental insufficiency, which may lead to:
- Intrauterine growth restriction (the baby not growing as expected) [5].
- Oligohydramnios (low amniotic fluid) [5].
- Premature birth or low birth weight [5][6].
- Increased risk of stillbirth or neonatal death [1].
It is vital to understand that severe outcomes like stillbirth are associated primarily with uncontrolled or severe disease—they are not inevitable. Prompt, specialized treatment drastically reduces these risks.
Medication Safety and Washout Planning
If you are planning a pregnancy, you must create a preconception plan with your doctor immediately. Some GPP treatments are teratogenic, meaning they can cause severe birth defects:
- Acitretin: Must be stopped at least three years after your last dose before attempting pregnancy due to how long it stays in the body. This requires strict contraception and alcohol precautions [7][8].
- Methotrexate: Requires a strict, prescriber-directed washout interval prior to conception [7].
Pregnancy data for newer biologics like spesolimab are limited, and drugs like secukinumab should not be assumed perfectly safe [2][9]. Decisions regarding biologics during pregnancy, breastfeeding safety, and precautions regarding infant live-vaccines must be made directly with your specialist team, weighing the risk of uncontrolled GPP without stopping effective treatment on your own.
Building Your Care Team
Because GPP can affect multiple systems in your body, a single doctor is rarely enough. A comprehensive care team often includes:
- Dermatologist: To lead your skin and systemic treatment plan.
- Rheumatologist: If you experience joint pain or swelling (psoriatic arthritis) [3].
- Maternal-Fetal Medicine Specialist: To manage preconception planning and the unique risks of pregnancy.
- Psychologist or Counselor: To help manage the “flare anxiety” and the emotional toll of living with a rare, unpredictable disease [10].
Routine Monitoring and Daily Life
Between flares, your “maintenance” phase involves regular surveillance to catch early signs of a flare or medication side effects. Routine testing is highly individualized and depends entirely on the specific drug you are taking. Your doctor will likely order routine monitoring, such as:
- Liver Enzymes: Especially if you are on methotrexate or acitretin [7][11].
- Lipid Profile: Acitretin can raise cholesterol and triglyceride levels [11][12].
- Kidney Function and Blood Pressure: If you are taking cyclosporine.
- C-Reactive Protein (CRP): To track baseline inflammation levels, though a normal CRP does not completely exclude clinically important disease [13].
Managing ‘Flare Anxiety’
It is normal to feel significant anxiety or fear about when the next flare might happen [10]. Research shows that patients with GPP often experience higher levels of emotional stress and stigma than those with common plaque psoriasis [14][15]. This “flare anxiety” can make it difficult to plan life events or work confidently [16]. Discussing these feelings openly with your care team is vital. Stress may be one contributor among many, but stress-reduction support can improve coping rather than guarantee flare prevention [16][17]. Finding a support network—whether through a patient advocacy group or professional counseling—can help you regain a sense of control over your life.
Common questions in this guide
Can pregnancy trigger a generalized pustular psoriasis flare?
How long should I wait after taking acitretin before trying to conceive?
What washout plan is needed for methotrexate before pregnancy?
Which specialists should be involved in GPP care during pregnancy?
What tests may be needed to monitor long-term GPP treatment?
How can I cope with anxiety about future GPP flares?
Can biologic medicines be used during pregnancy, and could they affect my baby's live vaccines?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Can we schedule a preconception consultation to discuss exact medication washout periods well before I try to become pregnant?
- 2.Which members of the maternal-fetal medicine team will you coordinate with if I experience a flare during pregnancy?
- 3.Based on my specific maintenance medication, exactly which routine labs (like liver enzymes or lipids) do I need, and how often?
- 4.What specific resources or patient advocacy groups do you recommend for managing the anxiety and psychological stress associated with GPP?
- 5.If I am taking a biologic medication during pregnancy, how might that affect my baby's live-vaccination schedule after birth?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Generalized Pustular Psoriasis in Pregnancy: Current and Future Treatments.
Seishima M, Fujii K, Mizutani Y
American journal of clinical dermatology 2022; (23(5)):661-671 doi:10.1007/s40257-022-00698-9.
PMID: 35704168 - 2
Spesolimab for treatment of generalized pustular psoriasis of pregnancy.
Bunn J, Henricks C, Azhar A, et al.
Pregnancy (Hoboken, N.J.) 2026; (2(1)):e70196 doi:10.1002/pmf2.70196.
PMID: 42597170 - 3
Clinical Course and Characteristics of Generalized Pustular Psoriasis.
Choon SE, Navarini AA, Pinter A
American journal of clinical dermatology 2022; (23(Suppl 1)):21-29 doi:10.1007/s40257-021-00654-z.
PMID: 35061227 - 4
Acute Respiratory Distress Syndrome in a Carrier of an Interleukin-36 Receptor Antagonist Mutation With Generalized Pustular Psoriasis.
Baniel A, Bar-Ilan E, Hilerowicz Y, et al.
Journal of psoriasis and psoriatic arthritis 2022; (7(1)):9-12 doi:10.1177/24755303211051724.
PMID: 39296731 - 5
Pustular psoriasis of pregnancy: Clinical and genetic characteristics in a series of eight patients and review of the literature.
Ennouri M, Bahloul E, Sellami K, et al.
Dermatologic therapy 2022; (35(8)):e15593 doi:10.1111/dth.15593.
PMID: 35598320 - 6
Treatment of Generalized Pustular Psoriasis of Pregnancy With Infliximab.
Beksac B, Adisen E, Gurer MA
Cutis 2021; (107(3)):E2-E5 doi:10.12788/cutis.0210.
PMID: 33956611 - 7
Clinical analysis of generalized pustular psoriasis in Chinese patients: A retrospective study of 110 patients.
Zheng J, Chen W, Gao Y, et al.
The Journal of dermatology 2021; (48(9)):1336-1342 doi:10.1111/1346-8138.15958.
PMID: 34018629 - 8
Successful treatment of generalized pustular psoriasis with chronic hepatitis B using spesolimab: A case report.
Ming R, Zhang L, Xiong X
Medicine 2025; (104(17)):e41979 doi:10.1097/MD.0000000000041979.
PMID: 40295264 - 9
Successful treatment of recalcitrant generalized pustular psoriasis of pregnancy with spesolimab.
Yang C, Wang Y, Li R, et al.
The Journal of dermatological treatment 2024; (35(1)):2334791 doi:10.1080/09546634.2024.2334791.
PMID: 38565205 - 10
Patient Experiences on the Diagnosis, Management, and Burden of Generalized Pustular Psoriasis: An International Web Survey and Qualitative Interview Study.
Lebwohl M, Fujita H, Eyerich K, et al.
Journal of psoriasis and psoriatic arthritis 2025; 24755303251401112 doi:10.1177/24755303251401112.
PMID: 41323249 - 11
Real-world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis.
Miao C, Chen Y, Wang Z, et al.
The Journal of dermatology 2023; (50(2)):258-261 doi:10.1111/1346-8138.16551.
PMID: 35983654 - 12
An analysis of psoriasis hospitalisation in Thailand.
Chaiyabutr C, Silpa-Archa N, Wongpraprarut C, et al.
Archives of dermatological research 2023; (315(4)):779-786 doi:10.1007/s00403-022-02429-w.
PMID: 36308558 - 13
Comparison of Severity Assessment Methods in Generalized Pustular Psoriasis: A Single-Center Study.
Ozaki M, Hayama K, Fujita H
The Journal of dermatology 2026; (53(5)):851-855 doi:10.1111/1346-8138.70232.
PMID: 41882954 - 14
The Disease Burden of Generalized Pustular Psoriasis: Real-World Evidence From CorEvitas' Psoriasis Registry.
Lebwohl M, Medeiros RA, Mackey RH, et al.
Journal of psoriasis and psoriatic arthritis 2022; (7(2)):71-78 doi:10.1177/24755303221079814.
PMID: 39296823 - 15
Internalized stigma in psoriasis: A multicenter study.
Alpsoy E, Polat M, FettahlıoGlu-Karaman B, et al.
The Journal of dermatology 2017; (44(8)):885-891 doi:10.1111/1346-8138.13841.
PMID: 28407292 - 16
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey.
Reisner DV, Johnsson FD, Kotowsky N, et al.
American journal of clinical dermatology 2022; (23(Suppl 1)):65-71 doi:10.1007/s40257-021-00663-y.
PMID: 35061229 - 17
A Global Assessment of Patient Experience and Quality of Life in Generalized Pustular Psoriasis: Results from Interviews and Online Surveys.
Kole LCS, Tada Y, Gerdes S, et al.
Dermatology and therapy 2025; (15(10)):3037-3053 doi:10.1007/s13555-025-01483-2.
PMID: 40775186
This page is for informational purposes only and does not constitute medical advice. Discuss pregnancy planning, medication changes, and monitoring with your dermatologist and maternal-fetal medicine team.
Get notified when new evidence is published on Generalized pustular psoriasis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.